
Stock Earnings
Oppenheimer Upgrades Biomarin Pharmaceutical Inc (BMRN) to an Outperform from a Perform
Biomarin Pharmaceutical Inc’s recent filing unveils that its GVP, Chief Accounting Officer Burkhart Erin unloaded Company’s shares for reported $0.11